Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells

Experimental and Molecular Medicine

Volumn 41, Issue 2, 2009, Pages 102-115

  Yoo, Hee Jung ^a   Yun, Bo Ra ^a   Kwon, Jung Hee ^b   Ahn, Hyuk Soo ^a   Seol, Min A ^a   Lee, Mi Jin ^a   Yu, Goung Ran ^a   Yu, Hee Chul ^a   Hong, BeeHak ^b   Choi, KwanYong ^b   Kim, Dae Ghon ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Cholangiocarcinoma; Gene expression profiling; Oligonucleotide array sequence analysis; Sarcoma

Indexed keywords

CARRIER PROTEIN; COMPLEMENTARY DNA; FAS ANTIGEN; FAS LIGAND; FRAGILE HISTIDINE TRIAD PROTEIN; GLUTATHIONE PEROXIDASE 1; PROTEIN ANXA9; PROTEIN ASPH; PROTEIN CALB1; PROTEIN CCND2; PROTEIN CES1; PROTEIN LDHB; PROTEIN LGALS1; PROTEIN MAL2; PROTEIN P53; PROTEIN S100P; PROTEIN TGFB1; PROTEIN UCHL1; PROTEIN VIL2; TUMOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; ACID ANHYDRIDE HYDROLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; SARCOMA; TUMOR SUPPRESSOR GENE; ANIMAL; BAGG ALBINO MOUSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MUTATION; TUMOR CELL LINE;

ACID ANHYDRIDE HYDROLASES; ANIMALS; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED BALB C; MUTATION; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SARCOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 63849291020     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.2.013     Document Type: Article

References (31)

1. Ahrendt SA, Nakeeb A, Pitt HA. Cholangiocarcinoma. Clin Liver Dis 2001;5:191-221
2. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2:84-89
3. Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996;156:217-226
4. Boyer B, Roche S, Denoyelle M, Thiery JP. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J 1997;16:5904-5913 (Pubitemid 27427286)
5. Chang WW, Agha FP, Morgan WS. Primary sarcoma of the liver in the adult. Cancer 1983;51:1510-1517 (Pubitemid 13162147)
6. Chen Y, Zhang H, Xu A, Li N, Liu J, Liu C, Lv D, Wu S, Huang L, Yang S, He D, Xiao X. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 2006;54:95-102
7. D'Errico A, Baccarini P, Fiorentino M, Ceccarelli C, Bonazzi C, Ponzetto A, Scoazec JY, Mancini AM, Grigioni WF. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol 1996;27:599-604 (Pubitemid 26187286)
8. Eger A, Stockinger A, Schaffhauser B, Beug H, Foisner R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of betacatenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J Cell Biol 2000; 148:173-188 (Pubitemid 30046791)
9. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985;55: 124-135
10. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 1997;150:483-495 (Pubitemid 27073779)
11. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jen J. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol 1999;155:711-715 (Pubitemid 29426816)
12. Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Higashiyama S, Monden M, Matsuura N. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma. Pathol Res Pract 2001;197:95-100 (Pubitemid 32194502)
13. Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer 1987; 59:310-316
14. Kim DG, Park SY, You KR, Lee GB, Kim H, Moon WS, Chun YH, Park SH. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding. Genes Chromosomes Cancer 2001;30:48-56
15. Levine AJ. The p53 tumor-suppressor gene. N Engl J Med 1992;326:1350-1352
16. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994;204:468-474 (Pubitemid 24343944)
17. Oda Y, Katsuda S, Nakanishi I. An autopsy case of hepatic sarcomatoid tumor: immunohistochemical comparison with a sarcomatous component of hepatocellular carcinoma. Pathol Int 1994;44:230-236 (Pubitemid 24094729)
18. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-597 (Pubitemid 26071739)
19. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 1995;9:1227-1232
20. Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ. Cholangiocarcinomas express Fas ligand and disable the Fas receptor. Hepatology 1999;30:1398-1404
21. Sarkar A, Yang P, Fan YH, Mu ZM, Hauptmann R, Adolf GR, Stass SA, Chang KS. Regulation of the expression of annexin VIII in acute promyelocytic leukemia. Blood 1994;84:279-286 (Pubitemid 24193831)
22. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelialmesenchymal transition. J Cell Biol 1997;137:1403-1419 (Pubitemid 27265951)
23. Shimonishi T, Isse K, Shibata F, Aburatani I, Tsuneyama K, Sabit H, Harada K, Miyazaki K, Nakanuma Y. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance. Hepatology 2000;32:761-769
24. Sozzi G, Alder H, Tornielli S, Corletto V, Baffa R, Veronese ML, Negrini M, Pilotti S, Pierotti MA, Huebner K, Croce CM. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 1996;56:2472-2474 (Pubitemid 26170675)
25. Thiagalingam S, Lisitsyn NA, Hamaguchi M, Wigler MH, Willson JK, Markowitz SD, Leach FS, Kinzler KW, Vogelstein B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996;56:2936-2939 (Pubitemid 26199735)
26. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121 (Pubitemid 32397092)
27. Wong H, Anderson WD, Cheng T, Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 1994;223:251-258
28. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 1996;149:1167-1175
29. Wu W, Glinka A, Delius H, Niehrs C. Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/betacatenin signalling. Curr Biol 2000;10:1611-1614 (Pubitemid 32062666)
30. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T, Nakao A. PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 2002;8:192-195 (Pubitemid 34101477)
31. You KR, Shin MN, Park RK, Lee SO, Kim DG. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells. Hepatology 2001;34:1119-1127 (Pubitemid 33096584)